Immunic
IMUX
HK$6.98
Share price
1.83%
Change (1 day)
-32.01%
Change (1 year)
Categories
Immunic (IMUX) - Cash on Hand
Cash on Hand as of December 2024 : HK$0.27 Billion
According to Immunic's latest financial reports the company has HK$0.27 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Immunic - Cash on Hand chart (from 2012 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | HK$0.36 B | -59.91% |
| 2022-12-31 | HK$0.90 B | 34.24% |
| 2021-12-31 | HK$0.67 B | -31.45% |
| 2020-12-31 | HK$0.98 B | 331.97% |
| 2019-12-31 | HK$0.22 B | 119.22% |
| 2018-12-31 | HK$0.10 B | -76.53% |
| 2017-12-31 | HK$0.44 B | -4.44% |
| 2016-12-31 | HK$0.46 B | -28.05% |
| 2015-12-31 | HK$0.64 B | -18.47% |
| 2014-12-31 | HK$0.79 B | 167.81% |
| 2013-12-31 | HK$0.29 B | 106.8% |
| 2012-12-31 | HK$0.14 B | 2195.85% |
| 2011-12-31 | HK$6.23 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 | HK$1.98 B | 617.62% | 🇺🇸 USA |